Evidence-Based Medicine Guidelines
Targeted therapy in first-line for advanced renal cell carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Targeted Therapy in First-line for Advanced Renal Cell Carcinoma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457371/all/Targeted_therapy_in_first_line_for_advanced_renal_cell_carcinoma.
Targeted therapy in first-line for advanced renal cell carcinoma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457371/all/Targeted_therapy_in_first_line_for_advanced_renal_cell_carcinoma. Accessed September 8, 2024.
Targeted therapy in first-line for advanced renal cell carcinoma. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457371/all/Targeted_therapy_in_first_line_for_advanced_renal_cell_carcinoma
Targeted Therapy in First-line for Advanced Renal Cell Carcinoma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457371/all/Targeted_therapy_in_first_line_for_advanced_renal_cell_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Targeted therapy in first-line for advanced renal cell carcinoma
ID - 457371
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457371/all/Targeted_therapy_in_first_line_for_advanced_renal_cell_carcinoma
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
